These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19347085)

  • 1. Vitiligo as an adverse reaction to topical diphencyprone.
    Pan JY; Theng C; Lee J; Goh BK
    Ann Acad Med Singap; 2009 Mar; 38(3):276-7. PubMed ID: 19347085
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo as a reaction to topical treatment with diphencyprone.
    Hatzis J; Gourgiotou K; Tosca A; Varelzidis A; Stratigos J
    Dermatologica; 1988; 177(3):146-8. PubMed ID: 3169339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo and topical allergens.
    Orecchia G; Perfetti L
    Dermatologica; 1989; 179(3):137-8. PubMed ID: 2591620
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitiligo following diphencyprone dermatitis.
    MacDonald-Hull SP; Cotterill JA; Norris JF
    Br J Dermatol; 1989 Feb; 120(2):323. PubMed ID: 2522312
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistent vitiligo induced by diphencyprone.
    Duhra P; Foulds IS
    Br J Dermatol; 1990 Sep; 123(3):415-6. PubMed ID: 2206982
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical immunotherapy with diphencyprone in the treatment of extensive and/or long-lasting alopecia areata.
    Firooz A; Bouzari N; Mojtahed F; Pazoki-Toroudi H; Nassiri-Kashani M; Davoudi M; Dowlati Y
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):393-4. PubMed ID: 15857483
    [No Abstract]   [Full Text] [Related]  

  • 7. Generalized urticaria with use of diphencyprone in the treatment of warts.
    Culp BL; Wells MJ
    J Drugs Dermatol; 2007 May; 6(5):529-30. PubMed ID: 17679188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of alopecia areata with diphencyprone.
    Hatzis J; Georgiotouo K; Kostakis P; Anastasiadis G; Tosca A; Varelzidis A; Straigos J
    Australas J Dermatol; 1988 Apr; 29(1):33-6. PubMed ID: 2977943
    [No Abstract]   [Full Text] [Related]  

  • 9. Response rates of cutaneous melanoma metastases to diphencyprone: A meta-analysis.
    Lôbo MM; Calsavara VF; Ricci BV; Lopes Pinto CA; Bertolli E; Duprat Neto JP
    J Am Acad Dermatol; 2020 Dec; 83(6):1812-1813. PubMed ID: 32289400
    [No Abstract]   [Full Text] [Related]  

  • 10. TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.
    Martiniuk F; Damian DL; Thompson JF; Scolyer RA; Tchou-Wong KM; Levis WR
    J Drugs Dermatol; 2010 Nov; 9(11):1368-72. PubMed ID: 21061759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of alopecia areata of the eyebrow with diphenylcyclopropenone and its possible risks].
    Lutz G; Kreysel HW
    Z Hautkr; 1989 Oct; 64(10):898-900. PubMed ID: 2588751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical immunotherapy with diphenylcyclopropenone in vitiligo: a preliminary experience.
    Aghaei S; Ardekani GS
    Indian J Dermatol Venereol Leprol; 2008; 74(6):628-31. PubMed ID: 19171989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provoking factors, including chemicals, in Dutch patients with vitiligo.
    Vrijman C; Hosseinpour D; Bakker JG; Wolkerstorfer A; Bos JD; van der Veen JP; Luiten RM
    Br J Dermatol; 2013 May; 168(5):1003-11. PubMed ID: 23252956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis.
    Henderson CA; Ilchyshyn A
    Br J Dermatol; 1995 Sep; 133(3):496-7. PubMed ID: 8547018
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of molluscum contagiosum with topical diphencyprone therapy.
    Kang SH; Lee D; Hoon Park J; Cho SH; Lee SS; Park SW
    Acta Derm Venereol; 2005; 85(6):529-30. PubMed ID: 16396805
    [No Abstract]   [Full Text] [Related]  

  • 16. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone.
    Damian DL; Thompson JF
    J Am Acad Dermatol; 2007 May; 56(5):869-71. PubMed ID: 17276544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo.
    Ganzetti G; Simonetti O; Campanati A; Giuliodori K; Offidani A
    Acta Derm Venereol; 2010 Nov; 90(6):642-3. PubMed ID: 21057754
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical diphencyprone for Kaposi sarcoma.
    Abdelmaksoud A
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28133860
    [No Abstract]   [Full Text] [Related]  

  • 20. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.